Patent Assignment
Reel/Frame 029806/0793
Assignment of Assignor's Interest
Recorded: 2013-02-13
Pages: 3
Assignor
HOLERS, V. MICHAEL
Executed: 2012-06-25
Assignee
ALEXION CAMBRIDGE CORPORATION
352 KNOTTER DRIVE, CHESHIRE, CONNECTICUT, 06410
Covered Properties
(2)
Treatment of Paroxysmal Nocturnal Hemoglobinuria, Hemolytic Anemias and Disease States Involving Intravascular and Extravascular Hemolysis
Patent:
10,239,937 →
Application:
13/505,150 →
Publication:
US 2013/0029912
PCT:
PCT/US2010/055745 ↗
Treatment of paroxysmal nocturnal hemoglobinuria and disease states involving intravascular and extravascular hemolysis
Application:
61/280,567 →
Related Assignments
(4)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Jan 27, 2011
From: HOLERS, V. MICHAEL
To: TALIGEN THERAPEUTICS, INC.
Reel/Frame 025709/0001 →
Assignment of Assignor's Interest
Feb 13, 2013
From: HOLERS, V. MICHAEL
To: TALIGEN THERAPEUTICS, INC.
Reel/Frame 029806/0659 →
Change of Name
Feb 13, 2013
From: TALIGEN THERAPEUTICS, INC.
To: ALEXION CAMBRIDGE CORPORATION
Reel/Frame 029806/0744 →
Merger
Jun 19, 2015
From: ALEXION CAMBRIDGE CORPORATION
To: ALEXION PHARMACEUTICALS, INC.
Reel/Frame 035866/0477 →